EMBC - Embecta Corp.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$5.00
DETAILS
HIGH:
$5.00
LOW:
$5.00
MEDIAN:
$5.00
CONSENSUS:
$5.00
UPSIDE:
50.60%
About Embecta Corp. (https://www.embecta.com)
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Devdatt Kurdikar | President, CEO & Chairman | 1969 | $2,400,080 USD |
| Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 1970 | $1,165,005 USD |
| Jacob Elguicze | Senior Vice President & Chief Financial Officer | 1973 | $1,159,024 USD |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary | 1972 | $1,105,340 USD |
| Jean Casner | Senior Vice President & Chief Human Resources Officer | 1958 | $854,983 USD |
| Anthony Roth | Vice President, Chief Accounting Officer & Corporate Controller | 1973 | $645,161 USD |
| Ginny Blocki | Senior Vice President of Strategy | – | – |
| Pravesh Khandelwal | Vice President & Head of Investor Relations | – | – |
| Slobodan Radumilo | Senior Vice President & President of International | 1971 | – |
| Tom Blount | Senior Vice President & President of North America | 1974 | – |